Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Wisconsin for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Wisconsin only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Wisconsin (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Debbie Lim (NPI 1477866325)

Field	Value
Entity Type	Individual
Organization	Debbie Lim
Address	2223 Lime Kiln Rd
City	Green Bay
State	WI
ZIP	54311
Taxonomy	Rheumatology Physician
NPI Enumerated	July 21, 2010

Payer Source	Total Paid
Medicare	$1.8M
Medicaid	$0

Key Findings

This provider’s Medicare footprint totals $1.8M in lifetime revenue while Medicaid activity is absent — none (no Medicaid billing on file) — indicating an effectively single‑payer (Medicare‑dominant) billing profile for public programs. The top three Medicare revenue drivers (precomputed) account for 62.7% of Medicare revenue, signaling concentrated dependence on a small set of services for the bulk of reported Medicare dollars.

Revenue is heavily concentrated in high‑cost biologic infusions consistent with a rheumatology infusion practice: J1745 ($422.6K, 23.0%), J9312 ($400.1K, 21.8%), and J3262 ($327.8K, 17.9%) together form the bulk of billing. Additional injectable biologics listed (J0129, J1602) plus infusion administration codes (96365, 96413, 96415) reinforce that the operation is infusion‑centric rather than primarily office E&M driven.

Top‑code concentration is meaningful at the single‑payer level: the precomputed top‑3 share of 62.7% shows that a small set of biologic drug codes disproportionately drives Medicare revenue, and the single largest line item, J1745, alone contributes $422.6K (23.0%). This concentration creates exposure to changes in coverage, pricing, or utilization policies for those specific biologics.

Competitive standing is mixed across individual drugs. For J1745 the provider ranks #23 of 1352 providers nationally (98th percentile) and is described as notably above typical national volume for this code, marking a nationally high volume position for infliximab; by contrast J9312 ranks #38 of 317 (88th percentile) and J3262 ranks #149 of 618 (76th percentile) but are both characterized in the file as typical, unremarkable volume for their codes.

There are statistical outliers in administration patterns that merit operational scrutiny: code 96415 (add‑on infusion hour) is listed as an extreme outlier, far above typical national volume (#64 of 4959, 99th percentile) despite contributing a modest $10.9K (0.6%) to Medicare revenue. Other administration/support codes show elevated national standing as well (for example J7050 ranks #92 of 1837, 95th percentile), suggesting high throughput in infusion sessions or extended infusion times compared with peers.

Office evaluation and management activity is present but small relative to infusion revenue: 99214 produced $50.7K (2.8% of Medicare revenue) and other E&M codes (99213, 99215, 99205) collectively account for only a small share of total Medicare dollars. This split supports the interpretation that clinical management and drug administration are the primary revenue engines rather than traditional visit‑based clinic throughput.

Operational and payer implications for networks and utilization management are clear: with $1.8M in Medicare revenue concentrated in biologic infusion codes and no Medicaid billing on file, payers should treat this entity as a Medicare‑centric infusion provider whose utilization patterns for infliximab and related biologics (especially J1745) will disproportionately influence negotiated volumes and cost exposure. Any policy changes affecting these specific J‑codes could materially change the provider’s Medicare revenue profile.

The provider has an established billing history with an NPI enumeration date of 2010-07-21 (~16 years ago), indicating sustained participation in Medicare over an extended period; combined with the high national rank on select infusion drugs, this suggests an entrenched operational model focused on outpatient biologic administration rather than a new or transient practice.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J1745	Injection, infliximab, excludes biosimilar, 10 mg	16,250	$30	$422.6K
J9312	Injection, rituximab, 10 mg	6,350	$60	$400.1K
J3262	Injection, tocilizumab, 1 mg	65,560	$10	$327.8K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	8,250	$30	$280.5K
J1602	Injection, golimumab, 1 mg, for intravenous use	22,450	$10	$224.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	600	$90	$50.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	510	$100	$49K
J0897	Injection, denosumab, 1 mg	1,080	$20	$19.4K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	280	$50	$13.3K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	520	$20	$10.9K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Wisconsin Distribution

Debbie Lim — 4 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Wisconsin

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	7	10	8,170	$30	$286.2K
J9312	2	10	2,580	$60	$234.8K
J1602	5	10	11,900	$10	$206.3K
J3262	2	10	35,280	$1	$191.4K
J1745	2	20	6,060	$30	$168.9K
J0897	54	60	2,220	$20	$69.3K
96413	1	80	110	$90	$12.7K
99214	133	9,800	80	$70	$9.2K
99215	1,649	3,320	30	$110	$6.3K
96365	9	90	50	$50	$5.8K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Debbie Lim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bellin Memorial Hospital Inc.	WI	General Acute Care Hospital	$0	$29.2M
Bellin Memorial Hospital Inc	WI	Family Medicine Physician	$0	$19.8M
Mercy Health System Corporation	WI	Multi-Specialty Clinic/Center	$0	$13.2M
Dickinson County Healthcare System	MI	General Acute Care Hospital	$0	$10.2M
Oconto Hospital & Medical Center Inc	WI	Critical Access Hospital	$0	$4.8M
Oconto Hospital & Medical Center Inc	WI	Rural Health Clinic/Center	$0	$4.2M
Bellin Psychiatric Center Inc.	WI	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$4.1M
Orthopedic Surgery Center Of Green Bay, LLC	WI	Ambulatory Surgical Clinic/Center	$2M	$0
Green Bay Emergency Medicine Services S.c.	WI	Emergency Medicine Physician	$0	$1.8M
Tower Clock Surgery Center LLC	WI	Ambulatory Surgical Clinic/Center	$1.2M	$428.6K

Nearby Providers

Other providers in the same ZIP code as Debbie Lim, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Eric Lund	WI	Clinical Psychologist	$0	$77.1M
Baycare Aurora, LLC	WI	General Acute Care Hospital	$0	$25.4M
County Of Brown	WI	Clinic/Center	$0	$21.1M
Caravel Autism Health, LLC	WI	Behavior Analyst	$0	$18.5M
County Of Brown	WI	Community/Behavioral Health Agency	$0	$8.2M
Visiting Nurse Association Of Wisconsin, Inc.	WI	Home Infusion Therapy Pharmacy	$0	$5M
Baycare Clinic LLP	WI	Emergency Medicine Physician	$0	$3.6M
County Of Brown	WI	Case Management Agency	$0	$3.3M
Aegis Group Inc	WI	Land Ambulance	$1.2M	$1.6M
Visiting Nurse Association Of Wisconsin, Inc	WI	Home Health Agency	$0	$2.7M

Debbie Lim — Billing Profile & Reimbursement Data

Sign up for Debbie Lim — Billing Profile & Reimbursement Data policy alerts

Debbie Lim — Billing Profile & Reimbursement Data

Sign up for Debbie Lim — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References